PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Mus

Go back to PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Mus
(NASDAQ: ELAB) Delayed: 4.64 -0.14 (2.93%)
Previous Close $4.78    52 Week High
Open $4.68    52 Week Low
Day High $4.74    P/E N/A 
Day Low $4.51    EPS
Volume 9,342       

(NASDAQ: ELAB) Delayed: 4.64 -0.14 (2.93%)
Previous Close $4.78    52 Week High
Open $4.68    52 Week Low
Day High $4.74    P/E N/A 
Day Low $4.51    EPS
Volume 9,342